Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-12-23 Purchase |
2022-12-28 4:05 pm |
Oncocyte Corp | OCX | Arno Andrew Director |
250,000 | $0.3515 | $87,875 | 562,049 (Indirect Direct) |
View |
| 2022-12-23 Purchase |
2022-12-28 4:05 pm |
Oncocyte Corp | OCX | Gutfreund John Peter Director |
75,000 | $0.3297 | $24,728 | 75,000 (Indirect) |
View |
| 2022-12-22 Purchase |
2022-12-27 6:47 pm |
Oncocyte Corp | OCX | KINGSLEY ALFRED D Director |
25,000 | $0.285 | $7,125 | 533,223 (Indirect Direct) |
View |
| 2022-12-01 Sale |
2022-12-20 4:05 pm |
Oncocyte Corp | OCX | Ross Douglas T. Former CSO. |
150,000 | $0 | $0 | 298,545 (Direct) |
View |
| 2022-12-01 Sale |
2022-12-20 4:05 pm |
Oncocyte Corp | OCX | Paulsen Gisela Former President and COO |
175,000 | $0 | $0 | 624,312 (Direct) |
View |
| 2022-08-17 Purchase |
2022-08-19 08:00 am |
Oncocyte Corp | OCX | Last Andrew J. Director |
20,000 | $0.87 | $17,400 | 70,170 (Direct) |
View |
| 2022-08-17 Purchase |
2022-08-19 08:00 am |
Oncocyte Corp | OCX | Arno Andrew Director |
15,000 | $0.9 | $13,500 | 15,000 (Indirect) |
View |
| 2022-08-16 Purchase |
2022-08-18 4:05 pm |
Oncocyte Corp | OCX | ANDREWS RONALD ASBURY President & CEO |
40,000 | $0.96 | $38,400 | 333,212 (Direct) |
View |
| 2022-08-15 Purchase |
2022-08-17 8:20 pm |
Oncocyte Corp | OCX | KINGSLEY ALFRED D Director |
10,000 | $0.97 | $9,700 | 553,223 (Indirect Direct) |
View |
| 2022-08-15 Purchase |
2022-08-17 8:19 pm |
Oncocyte Corp | OCX | Gutfreund John Peter Director |
25,000 | $0.93 | $23,250 | 80,000 (Indirect Direct) |
View |
| 2022-08-16 Purchase |
2022-08-17 8:18 pm |
Oncocyte Corp | OCX | GRIFFITH MELINDA Director |
10,000 | $1 | $10,000 | 75,000 (Direct) |
View |
| 2022-08-16 Purchase |
2022-08-17 8:17 pm |
Oncocyte Corp | OCX | Carter Jennifer L. Director |
10,500 | $0.95 | $9,975 | 75,500 (Direct) |
View |
| 2022-08-15 Purchase |
2022-08-17 8:15 pm |
Oncocyte Corp | OCX | Arno Andrew Director |
150,000 | $0.96081 | $144,121 | 327,049 (Direct) |
View |
| 2022-06-24 Sale |
2022-06-28 7:48 pm |
Oncocyte Corp | OCX | PURA VIDA INVESTMENTS LLC Kamen Efrem 10% Owner |
99,386 | $1.0327 | $102,635 | 8,479,682 (Indirect) |
View |
| 2022-04-14 Purchase(A) |
2022-06-28 7:46 pm |
Oncocyte Corp | OCX | PURA VIDA INVESTMENTS LLC Kamen Efrem 10% Owner |
200,000 | $1.2517 | $250,350 | 8,532,663 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-04-03 Option Award |
2023-04-05 9:30 pm |
N/A N/A |
Oncocyte Corp | OCX | Gutfreund John Peter Director |
1,705,000 | $0.3544 | 1,790,000 (Direct) |
View |
| 2023-04-03 Option Award |
2023-04-05 9:29 pm |
N/A N/A |
Oncocyte Corp | OCX | Arno Andrew Director |
141,084 | $0.3544 | 829,217 (Direct) |
View |
| 2023-03-06 Other |
2023-03-08 8:54 pm |
N/A N/A |
Oncocyte Corp | OCX | PURA VIDA INVESTMENTS LLC Kamen Efrem 10% Owner |
3,890,111 | $0 | 18,056,274 (Indirect) |
View |
| 2023-02-24 Option Award |
2023-02-28 5:59 pm |
N/A 2033-02-24 |
Oncocyte Corp | OCX | Riggs Josh CEO |
116,426 | $0 | 116,426 (Direct) |
View |
| 2023-02-24 Option Award |
2023-02-28 5:55 pm |
N/A 2033-02-24 |
Oncocyte Corp | OCX | John Anish M. Chief Financial Officer |
121,381 | $0 | 121,381 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-19 5:18 pm |
N/A 2033-01-17 |
Oncocyte Corp | OCX | Riggs Josh Interim CEO |
257,485 | $0 | 257,485 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-19 5:16 pm |
N/A 2033-01-17 |
Oncocyte Corp | OCX | Liu James Yang Controller, PAO |
57,065 | $0 | 57,065 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-19 5:14 pm |
N/A 2033-01-17 |
Oncocyte Corp | OCX | John Anish M. Chief Financial Officer |
250,466 | $0 | 250,466 (Direct) |
View |
| 2022-12-21 Option Award |
2022-12-22 6:57 pm |
N/A N/A |
Oncocyte Corp | OCX | Ross Douglas T. Former CSO |
213,797 | $0 | 234,114 (Direct) |
View |
| 2022-12-07 Option Award |
2022-12-09 8:23 pm |
N/A 2032-12-07 |
Oncocyte Corp | OCX | ANDREWS RONALD ASBURY Former CEO |
50,000 | $0 | 1,164,462 (Direct) |
View |
| 2022-12-01 Exercise |
2022-12-09 8:23 pm |
N/A N/A |
Oncocyte Corp | OCX | ANDREWS RONALD ASBURY Former CEO |
250,000 | $0 | 1,164,462 (Direct) |
View |
Ownership |
2022-12-09 8:21 pm |
N/A N/A |
Oncocyte Corp | OCX | SILVERMAN LOU Director |
0 | $0 | 34,257 (Direct) |
View |
Ownership |
2022-12-09 8:19 pm |
N/A N/A |
Oncocyte Corp | OCX | Riggs Josh Interim CEO |
0 | $0 | 467,320 (Direct) |
View |
Ownership |
2022-09-22 5:38 pm |
N/A 2032-03-15 |
Oncocyte Corp | OCX | Liu James Yang Controller, PAO |
0 | $0 | 87,260 (Direct) |
View |
| 2022-08-15 Option Award |
2022-08-17 8:24 pm |
N/A N/A |
Oncocyte Corp | OCX | Ross Douglas T. Chief Scientific Officer |
150,000 | $0 | 170,317 (Direct) |
View |
| 2022-08-15 Option Award |
2022-08-17 8:22 pm |
N/A N/A |
Oncocyte Corp | OCX | Paulsen Gisela President & COO |
525,000 | $0 | 541,500 (Direct) |
View |
| 2022-08-15 Option Award |
2022-08-17 8:21 pm |
N/A 2032-08-15 |
Oncocyte Corp | OCX | Last Andrew J. Director |
55,000 | $0 | 95,170 (Direct) |
View |
| 2022-08-15 Option Award |
2022-08-17 8:20 pm |
N/A 2032-08-15 |
Oncocyte Corp | OCX | KINGSLEY ALFRED D Director |
55,000 | $0 | 553,223 (Direct) |
View |
| 2022-08-15 Option Award |
2022-08-17 8:19 pm |
N/A 2032-08-15 |
Oncocyte Corp | OCX | John Anish M. Chief Financial Officer |
250,000 | $0 | 250,000 (Direct) |
View |
| 2022-08-15 Option Award |
2022-08-17 8:19 pm |
N/A 2032-08-15 |
Oncocyte Corp | OCX | Gutfreund John Peter Director |
55,000 | $0 | 80,000 (Direct) |
View |
| 2022-08-15 Option Award |
2022-08-17 8:18 pm |
N/A 2032-08-15 |
Oncocyte Corp | OCX | GRIFFITH MELINDA Director |
55,000 | $0 | 75,000 (Direct) |
View |
| 2022-08-15 Option Award |
2022-08-17 8:17 pm |
N/A 2032-08-15 |
Oncocyte Corp | OCX | Carter Jennifer L. Director |
55,000 | $0 | 75,500 (Direct) |
View |
| 2022-08-15 Option Award |
2022-08-17 8:15 pm |
N/A 2032-08-15 |
Oncocyte Corp | OCX | Arno Andrew Director |
55,000 | $0 | 327,049 (Direct) |
View |
Ownership |
2022-08-08 4:28 pm |
N/A N/A |
Oncocyte Corp | OCX | Gutfreund John Peter Director |
0 | $0 | 6,650,951 (Indirect) |
View |
| 2022-06-24 Exercise |
2022-07-19 4:05 pm |
N/A N/A |
Oncocyte Corp | OCX | Redmond Cavan M. Director |
10,000 | $0 | 120,863 (Direct) |
View |
| 2022-06-24 Exercise |
2022-07-19 4:05 pm |
N/A N/A |
Oncocyte Corp | OCX | GRIFFITH MELINDA Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-06-24 Exercise |
2022-07-19 4:05 pm |
N/A N/A |
Oncocyte Corp | OCX | Carter Jennifer L. Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-06-24 Exercise |
2022-07-19 4:05 pm |
N/A N/A |
Oncocyte Corp | OCX | KINGSLEY ALFRED D Director |
10,000 | $0 | 394,111 (Direct) |
View |
| 2022-06-24 Exercise |
2022-07-19 4:05 pm |
N/A N/A |
Oncocyte Corp | OCX | Arno Andrew Director |
10,000 | $0 | 122,049 (Direct) |
View |
| 2022-06-24 Exercise |
2022-07-19 4:05 pm |
N/A N/A |
Oncocyte Corp | OCX | Last Andrew J. Director |
10,000 | $0 | 40,170 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-15 7:49 pm |
N/A 2022-06-01 |
Oncocyte Corp | OCX | John Anish M. SVP, Finance, and Interim CFO |
50,000 | $0 | 50,000 (Direct) |
View |